nodes	percent_of_prediction	percent_of_DWPC	metapath
Erlotinib—CYP2D6—endogenous depression	0.669	1	CbGaD
Erlotinib—ORM1—saliva—endogenous depression	0.00594	0.027	CbGeAlD
Erlotinib—HIPK4—endocrine gland—endogenous depression	0.00272	0.0124	CbGeAlD
Erlotinib—NR1I2—endocrine gland—endogenous depression	0.00269	0.0122	CbGeAlD
Erlotinib—AURKC—adrenal gland—endogenous depression	0.00268	0.0122	CbGeAlD
Erlotinib—AURKC—thyroid gland—endogenous depression	0.00258	0.0118	CbGeAlD
Erlotinib—TNK1—pituitary gland—endogenous depression	0.00255	0.0116	CbGeAlD
Erlotinib—ULK3—forebrain—endogenous depression	0.00252	0.0115	CbGeAlD
Erlotinib—JAK3—adrenal gland—endogenous depression	0.00248	0.0113	CbGeAlD
Erlotinib—FLT3—cardiovascular system—endogenous depression	0.00247	0.0113	CbGeAlD
Erlotinib—PIP4K2C—adrenal cortex—endogenous depression	0.00245	0.0111	CbGeAlD
Erlotinib—JAK3—thyroid gland—endogenous depression	0.00239	0.0109	CbGeAlD
Erlotinib—ULK3—adrenal cortex—endogenous depression	0.00234	0.0106	CbGeAlD
Erlotinib—AURKC—endocrine gland—endogenous depression	0.00232	0.0106	CbGeAlD
Erlotinib—TNK1—adrenal gland—endogenous depression	0.00228	0.0104	CbGeAlD
Erlotinib—MKNK1—adrenal cortex—endogenous depression	0.0022	0.01	CbGeAlD
Erlotinib—TNK1—thyroid gland—endogenous depression	0.0022	0.01	CbGeAlD
Erlotinib—AURKC—nervous system—endogenous depression	0.00217	0.00989	CbGeAlD
Erlotinib—EPHA6—endocrine gland—endogenous depression	0.00215	0.00978	CbGeAlD
Erlotinib—JAK3—endocrine gland—endogenous depression	0.00215	0.00978	CbGeAlD
Erlotinib—AURKC—central nervous system—endogenous depression	0.00209	0.00952	CbGeAlD
Erlotinib—ABL2—pituitary gland—endogenous depression	0.00209	0.00951	CbGeAlD
Erlotinib—SLK—adrenal cortex—endogenous depression	0.00208	0.00948	CbGeAlD
Erlotinib—JAK3—nervous system—endogenous depression	0.00201	0.00916	CbGeAlD
Erlotinib—EPHA6—nervous system—endogenous depression	0.00201	0.00916	CbGeAlD
Erlotinib—MKNK1—cardiovascular system—endogenous depression	0.00201	0.00913	CbGeAlD
Erlotinib—PIP4K2C—pituitary gland—endogenous depression	0.00198	0.009	CbGeAlD
Erlotinib—TNK1—endocrine gland—endogenous depression	0.00197	0.00898	CbGeAlD
Erlotinib—FLT3—adrenal gland—endogenous depression	0.00196	0.0089	CbGeAlD
Erlotinib—HIPK4—brain—endogenous depression	0.00195	0.00885	CbGeAlD
Erlotinib—JAK3—central nervous system—endogenous depression	0.00194	0.00882	CbGeAlD
Erlotinib—EPHA6—central nervous system—endogenous depression	0.00194	0.00882	CbGeAlD
Erlotinib—LTK—brain—endogenous depression	0.00192	0.00876	CbGeAlD
Erlotinib—JAK3—cerebellum—endogenous depression	0.00189	0.00862	CbGeAlD
Erlotinib—ULK3—pituitary gland—endogenous depression	0.00189	0.00859	CbGeAlD
Erlotinib—ABL2—adrenal gland—endogenous depression	0.00187	0.0085	CbGeAlD
Erlotinib—MAP3K19—nervous system—endogenous depression	0.00183	0.00832	CbGeAlD
Erlotinib—EGFR—adrenal gland—endogenous depression	0.00182	0.00829	CbGeAlD
Erlotinib—MAP2K5—brainstem—endogenous depression	0.00181	0.00823	CbGeAlD
Erlotinib—ABL2—thyroid gland—endogenous depression	0.0018	0.0082	CbGeAlD
Erlotinib—MKNK1—pituitary gland—endogenous depression	0.00178	0.00809	CbGeAlD
Erlotinib—PIP4K2C—adrenal gland—endogenous depression	0.00177	0.00804	CbGeAlD
Erlotinib—MAP3K19—central nervous system—endogenous depression	0.00176	0.00801	CbGeAlD
Erlotinib—EGFR—thyroid gland—endogenous depression	0.00176	0.008	CbGeAlD
Erlotinib—PIP4K2C—midbrain—endogenous depression	0.00174	0.00794	CbGeAlD
Erlotinib—TNK1—cerebellum—endogenous depression	0.00174	0.00791	CbGeAlD
Erlotinib—PIP4K2C—thyroid gland—endogenous depression	0.0017	0.00776	CbGeAlD
Erlotinib—FLT3—endocrine gland—endogenous depression	0.0017	0.00772	CbGeAlD
Erlotinib—ULK3—adrenal gland—endogenous depression	0.00169	0.00768	CbGeAlD
Erlotinib—SLK—pituitary gland—endogenous depression	0.00168	0.00766	CbGeAlD
Erlotinib—ULK3—midbrain—endogenous depression	0.00167	0.00758	CbGeAlD
Erlotinib—AURKC—brain—endogenous depression	0.00166	0.00756	CbGeAlD
Erlotinib—STK10—cardiovascular system—endogenous depression	0.00165	0.00752	CbGeAlD
Erlotinib—ULK3—thyroid gland—endogenous depression	0.00163	0.00741	CbGeAlD
Erlotinib—MAP2K5—adrenal cortex—endogenous depression	0.00162	0.00736	CbGeAlD
Erlotinib—MKNK1—adrenal gland—endogenous depression	0.00159	0.00722	CbGeAlD
Erlotinib—MKNK1—midbrain—endogenous depression	0.00157	0.00713	CbGeAlD
Erlotinib—EPHA6—brain—endogenous depression	0.00154	0.007	CbGeAlD
Erlotinib—JAK3—brain—endogenous depression	0.00154	0.007	CbGeAlD
Erlotinib—MKNK1—thyroid gland—endogenous depression	0.00153	0.00697	CbGeAlD
Erlotinib—PIP4K2C—endocrine gland—endogenous depression	0.00153	0.00697	CbGeAlD
Erlotinib—SLK—adrenal gland—endogenous depression	0.0015	0.00684	CbGeAlD
Erlotinib—FLT3—cerebellum—endogenous depression	0.00149	0.0068	CbGeAlD
Erlotinib—SLK—midbrain—endogenous depression	0.00148	0.00675	CbGeAlD
Erlotinib—MAP2K5—cardiovascular system—endogenous depression	0.00148	0.00672	CbGeAlD
Erlotinib—ULK3—endocrine gland—endogenous depression	0.00146	0.00666	CbGeAlD
Erlotinib—SLK—thyroid gland—endogenous depression	0.00145	0.0066	CbGeAlD
Erlotinib—PIP4K2C—nervous system—endogenous depression	0.00143	0.00652	CbGeAlD
Erlotinib—ABL2—cerebellum—endogenous depression	0.00143	0.00649	CbGeAlD
Erlotinib—TNK1—brain—endogenous depression	0.00141	0.00643	CbGeAlD
Erlotinib—MAP3K19—brain—endogenous depression	0.0014	0.00636	CbGeAlD
Erlotinib—ABL1—brainstem—endogenous depression	0.0014	0.00635	CbGeAlD
Erlotinib—EGFR—cerebellum—endogenous depression	0.00139	0.00633	CbGeAlD
Erlotinib—PIP4K2C—central nervous system—endogenous depression	0.00138	0.00628	CbGeAlD
Erlotinib—MKNK1—endocrine gland—endogenous depression	0.00138	0.00626	CbGeAlD
Erlotinib—ULK3—nervous system—endogenous depression	0.00137	0.00623	CbGeAlD
Erlotinib—SLCO2B1—forebrain—endogenous depression	0.00136	0.00618	CbGeAlD
Erlotinib—PIP4K2C—cerebellum—endogenous depression	0.00135	0.00614	CbGeAlD
Erlotinib—ULK3—central nervous system—endogenous depression	0.00132	0.006	CbGeAlD
Erlotinib—STK10—adrenal gland—endogenous depression	0.00131	0.00595	CbGeAlD
Erlotinib—MAP2K5—pituitary gland—endogenous depression	0.00131	0.00595	CbGeAlD
Erlotinib—MKNK1—nervous system—endogenous depression	0.00129	0.00586	CbGeAlD
Erlotinib—ULK3—cerebellum—endogenous depression	0.00129	0.00586	CbGeAlD
Erlotinib—STK10—thyroid gland—endogenous depression	0.00126	0.00574	CbGeAlD
Erlotinib—ABL1—adrenal cortex—endogenous depression	0.00125	0.00568	CbGeAlD
Erlotinib—MKNK1—central nervous system—endogenous depression	0.00124	0.00565	CbGeAlD
Erlotinib—MKNK1—cerebellum—endogenous depression	0.00121	0.00552	CbGeAlD
Erlotinib—MAP2K5—adrenal gland—endogenous depression	0.00117	0.00531	CbGeAlD
Erlotinib—ABL2—brain—endogenous depression	0.00116	0.00527	CbGeAlD
Erlotinib—MAP2K5—midbrain—endogenous depression	0.00115	0.00525	CbGeAlD
Erlotinib—SLK—cerebellum—endogenous depression	0.00115	0.00523	CbGeAlD
Erlotinib—ABL1—cardiovascular system—endogenous depression	0.00114	0.00518	CbGeAlD
Erlotinib—STK10—endocrine gland—endogenous depression	0.00113	0.00516	CbGeAlD
Erlotinib—EGFR—brain—endogenous depression	0.00113	0.00514	CbGeAlD
Erlotinib—MAP2K5—thyroid gland—endogenous depression	0.00113	0.00513	CbGeAlD
Erlotinib—PIP4K2C—brain—endogenous depression	0.0011	0.00499	CbGeAlD
Erlotinib—UGT1A1—endocrine gland—endogenous depression	0.00107	0.00487	CbGeAlD
Erlotinib—STK10—nervous system—endogenous depression	0.00106	0.00483	CbGeAlD
Erlotinib—ULK3—brain—endogenous depression	0.00105	0.00476	CbGeAlD
Erlotinib—STK10—central nervous system—endogenous depression	0.00102	0.00465	CbGeAlD
Erlotinib—MAP2K5—endocrine gland—endogenous depression	0.00101	0.00461	CbGeAlD
Erlotinib—ABL1—pituitary gland—endogenous depression	0.00101	0.00459	CbGeAlD
Erlotinib—Gefitinib—CYP2D6—endogenous depression	0.001	1	CrCbGaD
Erlotinib—STK10—cerebellum—endogenous depression	0.000999	0.00454	CbGeAlD
Erlotinib—MKNK1—brain—endogenous depression	0.000985	0.00448	CbGeAlD
Erlotinib—CYP1B1—cardiovascular system—endogenous depression	0.000964	0.00439	CbGeAlD
Erlotinib—MAP2K5—nervous system—endogenous depression	0.000948	0.00431	CbGeAlD
Erlotinib—SLK—brain—endogenous depression	0.000933	0.00424	CbGeAlD
Erlotinib—MAP2K5—central nervous system—endogenous depression	0.000912	0.00415	CbGeAlD
Erlotinib—SLCO2B1—adrenal gland—endogenous depression	0.000909	0.00413	CbGeAlD
Erlotinib—ABL1—adrenal gland—endogenous depression	0.000901	0.0041	CbGeAlD
Erlotinib—MAP2K5—cerebellum—endogenous depression	0.000892	0.00406	CbGeAlD
Erlotinib—ABL1—midbrain—endogenous depression	0.000889	0.00405	CbGeAlD
Erlotinib—SLCO2B1—thyroid gland—endogenous depression	0.000877	0.00399	CbGeAlD
Erlotinib—ABL1—thyroid gland—endogenous depression	0.000869	0.00396	CbGeAlD
Erlotinib—CYP1B1—pituitary gland—endogenous depression	0.000854	0.00389	CbGeAlD
Erlotinib—ALB—adrenal gland—endogenous depression	0.000831	0.00378	CbGeAlD
Erlotinib—ORM1—endocrine gland—endogenous depression	0.000822	0.00374	CbGeAlD
Erlotinib—STK10—brain—endogenous depression	0.000811	0.00369	CbGeAlD
Erlotinib—SLCO2B1—endocrine gland—endogenous depression	0.000788	0.00359	CbGeAlD
Erlotinib—ABCG2—adrenal cortex—endogenous depression	0.000787	0.00358	CbGeAlD
Erlotinib—ABL1—endocrine gland—endogenous depression	0.000781	0.00355	CbGeAlD
Erlotinib—ORM1—nervous system—endogenous depression	0.000769	0.0035	CbGeAlD
Erlotinib—CYP1B1—adrenal gland—endogenous depression	0.000763	0.00347	CbGeAlD
Erlotinib—ORM1—central nervous system—endogenous depression	0.000741	0.00337	CbGeAlD
Erlotinib—SLCO2B1—nervous system—endogenous depression	0.000737	0.00336	CbGeAlD
Erlotinib—CYP1B1—thyroid gland—endogenous depression	0.000736	0.00335	CbGeAlD
Erlotinib—ABL1—nervous system—endogenous depression	0.000731	0.00333	CbGeAlD
Erlotinib—MAP2K5—brain—endogenous depression	0.000724	0.0033	CbGeAlD
Erlotinib—SLCO2B1—central nervous system—endogenous depression	0.00071	0.00323	CbGeAlD
Erlotinib—ABL1—central nervous system—endogenous depression	0.000704	0.0032	CbGeAlD
Erlotinib—SLCO2B1—cerebellum—endogenous depression	0.000694	0.00316	CbGeAlD
Erlotinib—ABL1—cerebellum—endogenous depression	0.000688	0.00313	CbGeAlD
Erlotinib—CYP1B1—endocrine gland—endogenous depression	0.000661	0.00301	CbGeAlD
Erlotinib—CYP2C8—pituitary gland—endogenous depression	0.000654	0.00298	CbGeAlD
Erlotinib—ABCG2—pituitary gland—endogenous depression	0.000636	0.00289	CbGeAlD
Erlotinib—CYP1B1—nervous system—endogenous depression	0.000619	0.00282	CbGeAlD
Erlotinib—CYP2D6—brainstem—endogenous depression	0.000603	0.00274	CbGeAlD
Erlotinib—CYP1B1—central nervous system—endogenous depression	0.000596	0.00271	CbGeAlD
Erlotinib—CYP1B1—cerebellum—endogenous depression	0.000583	0.00265	CbGeAlD
Erlotinib—CYP2D6—forebrain—endogenous depression	0.000582	0.00265	CbGeAlD
Erlotinib—ABCG2—adrenal gland—endogenous depression	0.000568	0.00258	CbGeAlD
Erlotinib—SLCO2B1—brain—endogenous depression	0.000564	0.00256	CbGeAlD
Erlotinib—ABCG2—midbrain—endogenous depression	0.000561	0.00255	CbGeAlD
Erlotinib—ABL1—brain—endogenous depression	0.000559	0.00254	CbGeAlD
Erlotinib—ABCG2—thyroid gland—endogenous depression	0.000548	0.00249	CbGeAlD
Erlotinib—CYP1A2—thyroid gland—endogenous depression	0.000528	0.0024	CbGeAlD
Erlotinib—CYP1A1—thyroid gland—endogenous depression	0.00052	0.00237	CbGeAlD
Erlotinib—ALB—brain—endogenous depression	0.000516	0.00235	CbGeAlD
Erlotinib—CYP2C8—endocrine gland—endogenous depression	0.000507	0.00231	CbGeAlD
Erlotinib—CYP1A2—endocrine gland—endogenous depression	0.000474	0.00216	CbGeAlD
Erlotinib—CYP1B1—brain—endogenous depression	0.000473	0.00215	CbGeAlD
Erlotinib—CYP1A1—endocrine gland—endogenous depression	0.000468	0.00213	CbGeAlD
Erlotinib—CYP3A5—endocrine gland—endogenous depression	0.000457	0.00208	CbGeAlD
Erlotinib—CYP1A1—nervous system—endogenous depression	0.000438	0.00199	CbGeAlD
Erlotinib—ABCG2—cerebellum—endogenous depression	0.000434	0.00197	CbGeAlD
Erlotinib—CYP1A1—central nervous system—endogenous depression	0.000421	0.00192	CbGeAlD
Erlotinib—ABCB1—forebrain—endogenous depression	0.000419	0.00191	CbGeAlD
Erlotinib—ABCB1—adrenal cortex—endogenous depression	0.000388	0.00177	CbGeAlD
Erlotinib—CYP2C8—brain—endogenous depression	0.000362	0.00165	CbGeAlD
Erlotinib—ABCB1—cardiovascular system—endogenous depression	0.000354	0.00161	CbGeAlD
Erlotinib—ABCG2—brain—endogenous depression	0.000352	0.0016	CbGeAlD
Erlotinib—CYP3A4—endocrine gland—endogenous depression	0.000343	0.00156	CbGeAlD
Erlotinib—CYP2D6—endocrine gland—endogenous depression	0.000338	0.00154	CbGeAlD
Erlotinib—CYP1A1—brain—endogenous depression	0.000335	0.00152	CbGeAlD
Erlotinib—CYP3A4—nervous system—endogenous depression	0.000321	0.00146	CbGeAlD
Erlotinib—CYP2D6—nervous system—endogenous depression	0.000316	0.00144	CbGeAlD
Erlotinib—ABCB1—pituitary gland—endogenous depression	0.000314	0.00143	CbGeAlD
Erlotinib—CYP3A4—central nervous system—endogenous depression	0.000309	0.00141	CbGeAlD
Erlotinib—CYP2D6—central nervous system—endogenous depression	0.000304	0.00138	CbGeAlD
Erlotinib—CYP2D6—cerebellum—endogenous depression	0.000297	0.00135	CbGeAlD
Erlotinib—ABCB1—adrenal gland—endogenous depression	0.00028	0.00127	CbGeAlD
Erlotinib—ABCB1—midbrain—endogenous depression	0.000277	0.00126	CbGeAlD
Erlotinib—ABCB1—thyroid gland—endogenous depression	0.00027	0.00123	CbGeAlD
Erlotinib—ABCB1—endocrine gland—endogenous depression	0.000243	0.00111	CbGeAlD
Erlotinib—CYP2D6—brain—endogenous depression	0.000242	0.0011	CbGeAlD
Erlotinib—ABCB1—nervous system—endogenous depression	0.000227	0.00103	CbGeAlD
Erlotinib—ABCB1—central nervous system—endogenous depression	0.000219	0.000996	CbGeAlD
Erlotinib—ABCB1—cerebellum—endogenous depression	0.000214	0.000973	CbGeAlD
Erlotinib—CYP1B1—Biological oxidations—COMT—endogenous depression	0.000205	0.00186	CbGpPWpGaD
Erlotinib—CYP1B1—Biological oxidations—MAOA—endogenous depression	0.000204	0.00184	CbGpPWpGaD
Erlotinib—CYP1B1—Metapathway biotransformation—COMT—endogenous depression	0.000202	0.00183	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—ANK3—endogenous depression	0.000202	0.00182	CbGpPWpGaD
Erlotinib—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.000201	0.00182	CbGpPWpGaD
Erlotinib—CYP1A2—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	0.0002	0.00181	CbGpPWpGaD
Erlotinib—EGFR—Axon guidance—CACNB2—endogenous depression	0.000199	0.0018	CbGpPWpGaD
Erlotinib—EGFR—MAPK Signaling Pathway—BDNF—endogenous depression	0.000195	0.00177	CbGpPWpGaD
Erlotinib—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—endogenous depression	0.000191	0.00172	CbGpPWpGaD
Erlotinib—CYP1A1—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.00019	0.00172	CbGpPWpGaD
Erlotinib—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—endogenous depression	0.000188	0.0017	CbGpPWpGaD
Erlotinib—JAK3—Signaling by GPCR—ADM—endogenous depression	0.000188	0.00169	CbGpPWpGaD
Erlotinib—JAK3—Immune System—WASF2—endogenous depression	0.000187	0.00169	CbGpPWpGaD
Erlotinib—EGFR—Axon guidance—CACNA1C—endogenous depression	0.000182	0.00164	CbGpPWpGaD
Erlotinib—JAK3—Immune System—WASF1—endogenous depression	0.00018	0.00162	CbGpPWpGaD
Erlotinib—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.000178	0.00161	CbGpPWpGaD
Erlotinib—CYP3A5—Biological oxidations—CYP2D6—endogenous depression	0.000177	0.0016	CbGpPWpGaD
Erlotinib—EGFR—Integrated Pancreatic Cancer Pathway—BDNF—endogenous depression	0.000176	0.00159	CbGpPWpGaD
Erlotinib—CYP3A5—Metapathway biotransformation—CYP2D6—endogenous depression	0.000174	0.00157	CbGpPWpGaD
Erlotinib—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.000174	0.00157	CbGpPWpGaD
Erlotinib—ABCB1—brain—endogenous depression	0.000174	0.000791	CbGeAlD
Erlotinib—JAK3—GPCR downstream signaling—OXT—endogenous depression	0.000173	0.00156	CbGpPWpGaD
Erlotinib—JAK3—GPCR downstream signaling—CRH—endogenous depression	0.000173	0.00156	CbGpPWpGaD
Erlotinib—ABCB1—Allograft Rejection—IL10—endogenous depression	0.000172	0.00156	CbGpPWpGaD
Erlotinib—CYP1A1—Biological oxidations—CYP2D6—endogenous depression	0.000167	0.00151	CbGpPWpGaD
Erlotinib—JAK3—GPCR downstream signaling—HTR1A—endogenous depression	0.000167	0.00151	CbGpPWpGaD
Erlotinib—ABL1—Developmental Biology—CACNB2—endogenous depression	0.000166	0.0015	CbGpPWpGaD
Erlotinib—ABL1—Innate Immune System—WASF2—endogenous depression	0.000165	0.00149	CbGpPWpGaD
Erlotinib—CYP1A1—Metapathway biotransformation—CYP2D6—endogenous depression	0.000165	0.00149	CbGpPWpGaD
Erlotinib—CYP3A5—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.000163	0.00147	CbGpPWpGaD
Erlotinib—JAK3—GPCR downstream signaling—HTR2C—endogenous depression	0.000161	0.00145	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—WASF2—endogenous depression	0.000161	0.00145	CbGpPWpGaD
Erlotinib—ABL1—Innate Immune System—WASF1—endogenous depression	0.000158	0.00143	CbGpPWpGaD
Erlotinib—JAK3—Signaling by GPCR—CRH—endogenous depression	0.000157	0.00142	CbGpPWpGaD
Erlotinib—JAK3—Signaling by GPCR—OXT—endogenous depression	0.000157	0.00142	CbGpPWpGaD
Erlotinib—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	0.000155	0.0014	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—WASF1—endogenous depression	0.000154	0.00139	CbGpPWpGaD
Erlotinib—CYP1A1—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.000154	0.00139	CbGpPWpGaD
Erlotinib—CYP2C8—Biological oxidations—CYP2D6—endogenous depression	0.000153	0.00138	CbGpPWpGaD
Erlotinib—ABL1—Developmental Biology—CACNA1C—endogenous depression	0.000152	0.00137	CbGpPWpGaD
Erlotinib—JAK3—Signaling by GPCR—HTR1A—endogenous depression	0.000151	0.00137	CbGpPWpGaD
Erlotinib—CYP2C8—Metapathway biotransformation—CYP2D6—endogenous depression	0.000151	0.00136	CbGpPWpGaD
Erlotinib—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.000151	0.00136	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—ADM—endogenous depression	0.000147	0.00133	CbGpPWpGaD
Erlotinib—JAK3—Signaling by GPCR—HTR2C—endogenous depression	0.000146	0.00132	CbGpPWpGaD
Erlotinib—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.000143	0.00129	CbGpPWpGaD
Erlotinib—UGT1A1—Biological oxidations—POMC—endogenous depression	0.000142	0.00129	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—CACNB2—endogenous depression	0.000142	0.00128	CbGpPWpGaD
Erlotinib—CYP2C8—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.000141	0.00127	CbGpPWpGaD
Erlotinib—JAK3—GPCR downstream signaling—HTR7—endogenous depression	0.000141	0.00127	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—WASF2—endogenous depression	0.000141	0.00127	CbGpPWpGaD
Erlotinib—CYP1A2—Phase II conjugation—COMT—endogenous depression	0.000138	0.00125	CbGpPWpGaD
Erlotinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—endogenous depression	0.000135	0.00122	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—WASF1—endogenous depression	0.000135	0.00122	CbGpPWpGaD
Erlotinib—CYP3A5—Biological oxidations—COMT—endogenous depression	0.000134	0.00121	CbGpPWpGaD
Erlotinib—CYP3A5—Biological oxidations—MAOA—endogenous depression	0.000133	0.0012	CbGpPWpGaD
Erlotinib—CYP1B1—Biological oxidations—POMC—endogenous depression	0.000133	0.0012	CbGpPWpGaD
Erlotinib—CYP3A5—Metapathway biotransformation—COMT—endogenous depression	0.000132	0.00119	CbGpPWpGaD
Erlotinib—ABL1—Hemostasis—GATA3—endogenous depression	0.00013	0.00118	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—CACNA1C—endogenous depression	0.00013	0.00117	CbGpPWpGaD
Erlotinib—JAK3—Signaling by GPCR—HTR7—endogenous depression	0.000128	0.00116	CbGpPWpGaD
Erlotinib—CYP1A1—Biological oxidations—COMT—endogenous depression	0.000126	0.00114	CbGpPWpGaD
Erlotinib—CYP1A1—Biological oxidations—MAOA—endogenous depression	0.000126	0.00113	CbGpPWpGaD
Erlotinib—CYP1A1—Metapathway biotransformation—COMT—endogenous depression	0.000125	0.00113	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—CRH—endogenous depression	0.000123	0.00111	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—OXT—endogenous depression	0.000123	0.00111	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—WASF2—endogenous depression	0.000121	0.00109	CbGpPWpGaD
Erlotinib—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.000121	0.00109	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—HTR1A—endogenous depression	0.000118	0.00107	CbGpPWpGaD
Erlotinib—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.000116	0.00105	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—WASF1—endogenous depression	0.000116	0.00105	CbGpPWpGaD
Erlotinib—CYP2C8—Biological oxidations—COMT—endogenous depression	0.000116	0.00105	CbGpPWpGaD
Erlotinib—CYP2D6—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.000116	0.00105	CbGpPWpGaD
Erlotinib—CYP2C8—Biological oxidations—MAOA—endogenous depression	0.000115	0.00104	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—HTR2C—endogenous depression	0.000114	0.00103	CbGpPWpGaD
Erlotinib—CYP2C8—Metapathway biotransformation—COMT—endogenous depression	0.000114	0.00103	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—ADM—endogenous depression	0.000111	0.001	CbGpPWpGaD
Erlotinib—CYP1A2—Biological oxidations—CYP2D6—endogenous depression	0.000106	0.000961	CbGpPWpGaD
Erlotinib—CYP1A2—Metapathway biotransformation—CYP2D6—endogenous depression	0.000105	0.000948	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—HTR7—endogenous depression	0.0001	0.000906	CbGpPWpGaD
Erlotinib—NR1I2—Gene Expression—NR3C1—endogenous depression	0.0001	0.000905	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—WASF2—endogenous depression	9.87e-05	0.000892	CbGpPWpGaD
Erlotinib—JAK3—GPCR downstream signaling—HTR2A—endogenous depression	9.87e-05	0.000892	CbGpPWpGaD
Erlotinib—CYP1A2—Phase 1 - Functionalization of compounds—POMC—endogenous depression	9.81e-05	0.000887	CbGpPWpGaD
Erlotinib—ABL1—Immune System—WASF2—endogenous depression	9.59e-05	0.000867	CbGpPWpGaD
Erlotinib—CYP2D6—Biological oxidations—COMT—endogenous depression	9.52e-05	0.00086	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—WASF1—endogenous depression	9.47e-05	0.000855	CbGpPWpGaD
Erlotinib—CYP2D6—Biological oxidations—MAOA—endogenous depression	9.45e-05	0.000854	CbGpPWpGaD
Erlotinib—CYP2D6—Metapathway biotransformation—COMT—endogenous depression	9.39e-05	0.000848	CbGpPWpGaD
Erlotinib—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	9.34e-05	0.000844	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—CRH—endogenous depression	9.28e-05	0.000839	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—OXT—endogenous depression	9.28e-05	0.000839	CbGpPWpGaD
Erlotinib—ABL1—Immune System—WASF1—endogenous depression	9.19e-05	0.000831	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—ADM—endogenous depression	9.03e-05	0.000816	CbGpPWpGaD
Erlotinib—JAK3—Signaling by GPCR—HTR2A—endogenous depression	8.96e-05	0.00081	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—HTR1A—endogenous depression	8.94e-05	0.000807	CbGpPWpGaD
Erlotinib—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—endogenous depression	8.9e-05	0.000804	CbGpPWpGaD
Erlotinib—CYP3A5—Biological oxidations—POMC—endogenous depression	8.65e-05	0.000782	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—HTR2C—endogenous depression	8.63e-05	0.00078	CbGpPWpGaD
Erlotinib—CYP3A4—Biological oxidations—CYP2D6—endogenous depression	8.21e-05	0.000742	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—ADM—endogenous depression	8.2e-05	0.000741	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—TPH1—endogenous depression	8.2e-05	0.000741	CbGpPWpGaD
Erlotinib—EGFR—Immune System—WASF2—endogenous depression	8.19e-05	0.000741	CbGpPWpGaD
Erlotinib—CYP1A1—Biological oxidations—POMC—endogenous depression	8.17e-05	0.000739	CbGpPWpGaD
Erlotinib—CYP3A4—Metapathway biotransformation—CYP2D6—endogenous depression	8.1e-05	0.000732	CbGpPWpGaD
Erlotinib—CYP1A2—Biological oxidations—COMT—endogenous depression	8.06e-05	0.000729	CbGpPWpGaD
Erlotinib—CYP1A2—Biological oxidations—MAOA—endogenous depression	8.01e-05	0.000723	CbGpPWpGaD
Erlotinib—CYP1A2—Metapathway biotransformation—COMT—endogenous depression	7.95e-05	0.000719	CbGpPWpGaD
Erlotinib—JAK3—GPCR downstream signaling—POMC—endogenous depression	7.88e-05	0.000712	CbGpPWpGaD
Erlotinib—EGFR—Immune System—WASF1—endogenous depression	7.86e-05	0.00071	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—TPH1—endogenous depression	7.65e-05	0.000691	CbGpPWpGaD
Erlotinib—CYP3A4—Phase 1 - Functionalization of compounds—POMC—endogenous depression	7.57e-05	0.000684	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—CRH—endogenous depression	7.57e-05	0.000684	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—OXT—endogenous depression	7.57e-05	0.000684	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—HTR7—endogenous depression	7.56e-05	0.000683	CbGpPWpGaD
Erlotinib—CYP2C8—Biological oxidations—POMC—endogenous depression	7.49e-05	0.000677	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—HTR1A—endogenous depression	7.28e-05	0.000658	CbGpPWpGaD
Erlotinib—JAK3—Signaling by GPCR—POMC—endogenous depression	7.16e-05	0.000647	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—HTR2C—endogenous depression	7.04e-05	0.000636	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—HTR2A—endogenous depression	7.02e-05	0.000634	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—TPH1—endogenous depression	6.96e-05	0.000629	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—CRH—endogenous depression	6.87e-05	0.000621	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—OXT—endogenous depression	6.87e-05	0.000621	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—HTR1A—endogenous depression	6.62e-05	0.000598	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—GATA3—endogenous depression	6.41e-05	0.00058	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—HTR2C—endogenous depression	6.39e-05	0.000577	CbGpPWpGaD
Erlotinib—CYP3A4—Biological oxidations—COMT—endogenous depression	6.22e-05	0.000562	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—TPH2—endogenous depression	6.21e-05	0.000562	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—CACNB2—endogenous depression	6.21e-05	0.000562	CbGpPWpGaD
Erlotinib—CYP3A4—Biological oxidations—MAOA—endogenous depression	6.18e-05	0.000558	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—HTR7—endogenous depression	6.16e-05	0.000557	CbGpPWpGaD
Erlotinib—CYP2D6—Biological oxidations—POMC—endogenous depression	6.15e-05	0.000556	CbGpPWpGaD
Erlotinib—CYP3A4—Metapathway biotransformation—COMT—endogenous depression	6.14e-05	0.000555	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—DPYD—endogenous depression	6.11e-05	0.000552	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—TPH2—endogenous depression	5.8e-05	0.000524	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—CACNB2—endogenous depression	5.8e-05	0.000524	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—DPYD—endogenous depression	5.7e-05	0.000515	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—CACNA1C—endogenous depression	5.68e-05	0.000514	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—POMC—endogenous depression	5.61e-05	0.000507	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—HTR7—endogenous depression	5.6e-05	0.000506	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—CACNA1C—endogenous depression	5.3e-05	0.000479	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—WASF2—endogenous depression	5.3e-05	0.000479	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—HTR2A—endogenous depression	5.29e-05	0.000478	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—TPH2—endogenous depression	5.27e-05	0.000476	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—CACNB2—endogenous depression	5.27e-05	0.000476	CbGpPWpGaD
Erlotinib—CYP1A2—Biological oxidations—POMC—endogenous depression	5.21e-05	0.000471	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—DPYD—endogenous depression	5.19e-05	0.000469	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism of lipids and lipoproteins—POMC—endogenous depression	5.1e-05	0.000461	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—WASF1—endogenous depression	5.08e-05	0.000459	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—TPH1—endogenous depression	4.98e-05	0.00045	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—CYP2D6—endogenous depression	4.97e-05	0.000449	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—ADM—endogenous depression	4.85e-05	0.000438	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—CACNA1C—endogenous depression	4.82e-05	0.000436	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—TPH1—endogenous depression	4.71e-05	0.000426	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—CYP2D6—endogenous depression	4.63e-05	0.000419	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—TPH1—endogenous depression	4.32e-05	0.00039	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—HTR2A—endogenous depression	4.32e-05	0.00039	CbGpPWpGaD
Erlotinib—ALB—Metabolism—TPH1—endogenous depression	4.29e-05	0.000388	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—POMC—endogenous depression	4.23e-05	0.000382	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—CYP2D6—endogenous depression	4.21e-05	0.000381	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CRH—endogenous depression	4.06e-05	0.000367	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—OXT—endogenous depression	4.06e-05	0.000367	CbGpPWpGaD
Erlotinib—CYP3A4—Biological oxidations—POMC—endogenous depression	4.02e-05	0.000363	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—HTR2A—endogenous depression	3.92e-05	0.000354	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—HTR1A—endogenous depression	3.91e-05	0.000353	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—TPH2—endogenous depression	3.78e-05	0.000341	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—CACNB2—endogenous depression	3.78e-05	0.000341	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—HTR2C—endogenous depression	3.78e-05	0.000341	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—COMT—endogenous depression	3.76e-05	0.00034	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—TPH1—endogenous depression	3.76e-05	0.00034	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—MAOA—endogenous depression	3.74e-05	0.000338	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—DPYD—endogenous depression	3.72e-05	0.000336	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—TPH2—endogenous depression	3.57e-05	0.000323	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—CACNB2—endogenous depression	3.57e-05	0.000323	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—TPH1—endogenous depression	3.54e-05	0.00032	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—COMT—endogenous depression	3.51e-05	0.000317	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—DPYD—endogenous depression	3.51e-05	0.000317	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—MAOA—endogenous depression	3.49e-05	0.000315	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—CACNA1C—endogenous depression	3.46e-05	0.000312	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—POMC—endogenous depression	3.45e-05	0.000311	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—HTR7—endogenous depression	3.31e-05	0.000299	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—TPH2—endogenous depression	3.27e-05	0.000296	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—CACNB2—endogenous depression	3.27e-05	0.000296	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—CACNA1C—endogenous depression	3.26e-05	0.000295	CbGpPWpGaD
Erlotinib—ALB—Metabolism—TPH2—endogenous depression	3.25e-05	0.000294	CbGpPWpGaD
Erlotinib—ALB—Metabolism—CACNB2—endogenous depression	3.25e-05	0.000294	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—DPYD—endogenous depression	3.22e-05	0.000291	CbGpPWpGaD
Erlotinib—ALB—Metabolism—DPYD—endogenous depression	3.2e-05	0.000289	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—COMT—endogenous depression	3.19e-05	0.000289	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—MAOA—endogenous depression	3.17e-05	0.000287	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism of lipids and lipoproteins—POMC—endogenous depression	3.14e-05	0.000284	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—POMC—endogenous depression	3.13e-05	0.000283	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—CYP2D6—endogenous depression	3.02e-05	0.000273	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—TPH1—endogenous depression	3e-05	0.000271	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—CACNA1C—endogenous depression	2.99e-05	0.00027	CbGpPWpGaD
Erlotinib—ALB—Metabolism—CACNA1C—endogenous depression	2.98e-05	0.000269	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism of lipids and lipoproteins—POMC—endogenous depression	2.88e-05	0.00026	CbGpPWpGaD
Erlotinib—ALB—Metabolism of lipids and lipoproteins—POMC—endogenous depression	2.86e-05	0.000259	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—CYP2D6—endogenous depression	2.85e-05	0.000258	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—TPH2—endogenous depression	2.85e-05	0.000258	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—CACNB2—endogenous depression	2.85e-05	0.000258	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—DPYD—endogenous depression	2.8e-05	0.000253	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—TPH2—endogenous depression	2.69e-05	0.000243	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—CACNB2—endogenous depression	2.69e-05	0.000243	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—DPYD—endogenous depression	2.64e-05	0.000239	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—CYP2D6—endogenous depression	2.62e-05	0.000236	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—CACNA1C—endogenous depression	2.61e-05	0.000236	CbGpPWpGaD
Erlotinib—ALB—Metabolism—CYP2D6—endogenous depression	2.6e-05	0.000235	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—CACNA1C—endogenous depression	2.46e-05	0.000222	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—POMC—endogenous depression	2.43e-05	0.00022	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—TPH1—endogenous depression	2.32e-05	0.000209	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—HTR2A—endogenous depression	2.32e-05	0.000209	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—COMT—endogenous depression	2.29e-05	0.000207	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—CYP2D6—endogenous depression	2.28e-05	0.000206	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—TPH2—endogenous depression	2.28e-05	0.000206	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—CACNB2—endogenous depression	2.28e-05	0.000206	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—MAOA—endogenous depression	2.27e-05	0.000205	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—POMC—endogenous depression	2.27e-05	0.000205	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—DPYD—endogenous depression	2.24e-05	0.000202	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—COMT—endogenous depression	2.16e-05	0.000195	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—MAOA—endogenous depression	2.15e-05	0.000194	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—CACNA1C—endogenous depression	2.08e-05	0.000188	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—POMC—endogenous depression	2.06e-05	0.000187	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—POMC—endogenous depression	2e-05	0.000181	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—COMT—endogenous depression	1.98e-05	0.000179	CbGpPWpGaD
Erlotinib—ALB—Metabolism—COMT—endogenous depression	1.97e-05	0.000178	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—MAOA—endogenous depression	1.97e-05	0.000178	CbGpPWpGaD
Erlotinib—ALB—Metabolism—MAOA—endogenous depression	1.96e-05	0.000177	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—POMC—endogenous depression	1.85e-05	0.000167	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—CYP2D6—endogenous depression	1.82e-05	0.000164	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—TPH2—endogenous depression	1.76e-05	0.000159	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—CACNB2—endogenous depression	1.76e-05	0.000159	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—DPYD—endogenous depression	1.73e-05	0.000156	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—COMT—endogenous depression	1.73e-05	0.000156	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—MAOA—endogenous depression	1.71e-05	0.000155	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—COMT—endogenous depression	1.63e-05	0.000147	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—MAOA—endogenous depression	1.62e-05	0.000146	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—CACNA1C—endogenous depression	1.61e-05	0.000145	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—POMC—endogenous depression	1.48e-05	0.000134	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—CYP2D6—endogenous depression	1.4e-05	0.000127	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—POMC—endogenous depression	1.4e-05	0.000126	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—COMT—endogenous depression	1.38e-05	0.000125	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—MAOA—endogenous depression	1.37e-05	0.000124	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—POMC—endogenous depression	1.28e-05	0.000116	CbGpPWpGaD
Erlotinib—ALB—Metabolism—POMC—endogenous depression	1.27e-05	0.000115	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—POMC—endogenous depression	1.12e-05	0.000101	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—COMT—endogenous depression	1.06e-05	9.62e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—MAOA—endogenous depression	1.06e-05	9.55e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—POMC—endogenous depression	1.05e-05	9.51e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—POMC—endogenous depression	8.91e-06	8.05e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—POMC—endogenous depression	6.88e-06	6.22e-05	CbGpPWpGaD
